[1] Page DL. Cancer risk assessment in benign breast biopsies[J]. Hum Pathol, 1986, 17(9):871-874.
[2]

阚秀, 陈定宝.再谈乳腺交界性病变与DIN分级系统[J/OL].中华乳腺病杂志(电子版), 2013, 7(3): 157-159[2014-10-08]. http://www.zhrxb22.com/oa/darticle.aspx?type=view&id=20130302.

[3] Lakhani SR. The transition from hyperplasia to invasive carcinoma of the breast[J]. J Pathol, 1999, 187(3):272-278.
[4] 赵玉梅, 郎荣刚, 张俊义.微小钙化在乳腺疾病X线诊断中的意义[J].天津医科大学学报, 2008, 14(2):219-222.
[5] 许艳春, 姚晓虹, 祝明洁.乳腺非典型性导管增生的研究进展[J].上海交通大学学报:医学版, 2013, 33(4):516-519.
[6]

李坤成, 孙泽民.乳腺影像诊断学[M].北京:人民卫生出版社, 2003:101-102.

[7] Murphy IG, Dillon MF, Doherty AO, et al. Analysis of patients with false negative mammography and symptomatic breast carcinoma[J]. J Surg Oncol, 2007, 96(6):457-463.
[8] Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging:recommentlations Irom the society of breast imaging and the ACR on the use of mammography, breast MRI, breast ultra-sound, and other technologies for the detection of clinically occult breast cancer[J]. J Am Coll Radiol, 2010, 7(1):18-27.
[9] 许光中, 李凯, 封国生. 3种影像学检查方法在乳腺癌早期诊断中的作用[J].首都医科大学学报, 2009, 30(3):293-297.
[10] Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy[J]. JAMA, 2004, 292(22):2375-2742.